Gut-on-a-Chip for Infectious Diseases: A Pathogen-Centric Review of Model Selection and Validation
BME Frontiers · 2026-01-01 · 7
DOI: 10.34133/bmef.0336 ↗Abstract
Gut-on-a-chip systems are microfluidic, 3-dimensional (3D) in vitro platforms designed to recapitulate selected intestinal features, including epithelial polarity, fluid flow, peristalsis-like deformation, mucus formation, oxygen gradients, and, in some designs, epithelial–endothelial or host–microbiome interactions. Rather than treating increasing structural complexity as an inherent surrogate for biological fidelity, this review evaluates gut-on-a-chip models according to the infectious-disease question being addressed, the specific biological functions reproduced, the measurable infection endpoints, and the level of experimental or translational validation. We synthesize evidence across bacterial, viral, and parasitic infections and compare the relative maturity of these applications. Bacterial models currently represent the most mature evidence base, whereas fungal infections are considered where direct gut-on-a-chip evidence remains limited. We further examine host–microbiome interactions and gut–organ-axis platforms only when they provide a mechanistic or translational perspective relevant to infection. Four major evidence gaps are identified: limited head-to-head benchmarking against established models or clinical observations, incomplete standardization of chip and infection parameters, limited culture duration and microbial complexity in many systems, and relatively sparse infection-specific applications of artificial intelligence. Finally, we propose a validation-oriented framework linking pathogen, biological question, required chip feature, measurable endpoint, and evidence level, and we clarify the current regulatory position of new approach methodologies (NAMs).
EUVIMED